Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 4/20 | 0.35 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 4/20 | 0.34 |
| ▸ | CDC25B | P30305 | 4/20 | 0.34 |
| ▸ | CDC25C | P30307 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SCD | O00767 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3825946 | 0.75 | PDE4B (0.38) | FBP1HCAR2ALDH1A1 | |
| SCHEMBL13566384 | 0.74 | KCNH2 (0.39) | FBP1ALDH1A1 | |
| SCHEMBL11741106 | 0.74 | P2RX3 (0.44) | ALDH1A1 | |
| SCHEMBL7501660 | 0.74 | SORT1 (0.40) | ALDH1A1 | |
| SCHEMBL4782648 | 0.71 | HCAR2 (0.41) | HCAR2HCAR3RARBALDH1A1 | |
| SCHEMBL7508066 | 0.71 | BCL2 (0.40) | HCAR2HCAR3ALDH1A1 | |
| SCHEMBL2717653 | 0.70 | ALDH1A1 (0.34) | FBP1ALDH1A1 | |
| SCHEMBL5701035 | 0.69 | HCAR2 (0.44) | HCAR2HCAR3RARBHAO1ALDH1A1 | |
| SCHEMBL17483050 | 0.68 | HCAR2 (0.41) | FBP1HCAR2HCAR3RARBHAO1 | |
| SCHEMBL2839466 | 0.68 | HCAR2 (0.41) | FBP1HCAR2HCAR3RARBHAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008087611-A2 | PYRROLIDINE- AND PIPERIDINE- BIS-AMIDE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-07-24 | — | — | WO | disclosed |